PROLOTHERAPY APPLICATION IN PATIENTS WITH LOW-BACK PAIN

Yıl 2020, Cilt: 2 Sayı: 2, 22 - 26, 29.12.2020

Hayriye Baltaoğlu Alp Reşat Uyar

Öz

Bel ağrısı, tüm toplumlarda her zaman karşılaşılan yaygın bir hastalıktır. Proloterapi, eski eklemleri, kıkırdak bağlarını ve tendonları güçlendirmek ve restore etmek için proliferant çözeltilerin enjeksiyonu ile karakterize edilen bir tedavi şeklidir. Eylül 2015 başından Ocak 2016 tarihleri arasında15 hastaya Kas gücü ve nörolojik muayeneden sonra lomber proloterapi protokolü uygulandı. Hastaya enjekte edildi (% 15 dekstroz 20 cc +% 2 lidokain 1cc). Ağrı değerlendirmesi için visural analog skala kullanıldı. Hastaların dağılımı 10 kadın, 5 erkek hasta idi. Yaş ortalaması 57,93 idi. 4 seans sonunda VAS değerleri anlamlı oranda azaldı. Proloterapi tekrarlayan sırt cerrahisi operasyonlarından sonra geçmeyen ağrılı durumlar da uygulanabilir. Başarısız bel cerrahisi öyküsü olan 79 hastadan oluşan seride, Solmaz ve ark. Solmaz ve arkadaşlarının proloterapi uygulamasından sonra VAS ve ODI indekslerinde anlamlı bir azalma saptandı. Birçok farmakolojik ve girişimsel tedaviye göre proloterapi etkili bir analjezi sağlayabilir

Anahtar Kelimeler

Proloterapi, bel ağrısı, analjezi

Destekleyen Kurum

yok

Proje Numarası

yok

Prolotherapy Applicatıon In Patients with Low-Back Pain

Öz

Aim Low back pain is a common disease . Prolotherapy is a form of treatment characterized by injection of proliferant solutions to strengthen and restore old joints, ligaments
and tendons.
Method Between September 2015 and January 2016, 15 patients underwent lumbar prolotherapy protocol after muscle strength and neurological examination. The patient was
injected (15% dextrose 20 cc + 2% lidocaine 1cc). Visural analog scale was used for pain assessment.
Result The distribution of patients was 10 female and 5 male patients. The average age was 57.93. After 4 sessions, VAS values decreased significantly. Painful conditions that do
not pass after prolotherapy repetitive back surgery operations can also be applied.
Conclussion The lowest was 30 years old, the highest was 85 years old. A total of 4 sessions were performed for each patient with an interval of 15 days. At the end of 4 sessions, VAS
results were evaluated as 8 of 10 female patients, VAS values of 0 (zero), VAS of 2 patients were evaluated as 2

Anahtar Kelimeler

Prolothrerapy, low-back pain, analgesia

Proje Numarası

yok

Kaynakça

• 1.Cabot D, Miller IL, Kelley JF. An algorithm for conservative back care. Pain Digest 1994; 4:269- 275.
• 2. Goertz MN. Prognostic indicators for acute low back pain. Spine 1990; 15:1307-1310.
• 3. Hoogendoorn WE, Van Poppel MN, Bongers PM, Koes BW, Bouter LM: Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 2000;25: 2114- 2125.
• 4. Kang JD, Gerrgoscu HI. Herniated lumbar intervertebral disc spontaneously produce matrix metalloproteinases, nitric oxide, interleukin 6 and prostoglandin E2. Spine 1996; 21:271-277.
• 5. Takahashi H, Suguna T. lnflammatory cytokines in the herniated disc in lumbar spine. Spine 1996; 2l:218-224.
• 6.Distel LM, Best TM: Prolotherapy: A clinical review of its role in treating chronic musculoskeletal pain. Arch Phys Med Rehabil2011; 3: 78-81.
• 7. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK: A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord 2016; 9: 139-160.
• 8. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56.
• 9. Miller C, Newton SE. Pain perception and expression: the influence of gender, personal self-efficacy, and lifespan socialization.Pain Manag Nurs 2006;7(4):148-52.
• 10. Robinson ME, Gagnon CM, Riley JL 3rd, Price DD. Altering gender role expectations: effects on pain tolerance, pain threshold, and pain ratings. J Pain 2003;4(5):284-8.
• 11. Erdine S, Hamzaoğlu O, Özkan Ö, Balta E, Domaç M. Türkiye’de erişkinlerin ağrı prevalansı. Ağrı. 2001;13(2):22-30.
• 12.Saragiotto BT1, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016 Jun 7;(6):CD012230.
• 13. Jonely H, Brismée JM, Desai MJ, Reoli R. Chronic sacroiliac joint and pelvic girdle dysfunction in a 35-year-old nulliparous woman successfully managed with multimodal and multidisciplinary approach. J Man Manip Ther. 2015 Feb;23(1):20-6.
• 14. Solmaz, İ., Akpancar, S., Örsçelik, A. et al. Dextrose injections for failed back surgery syndrome: a consecutive case series. Eur Spine J 28, 1610–1617 (2019). https://doi.org/10.1007/s00586-019-06011-3.
• 15. McCormick Z, Cushman D, Caldwell M, Marshall B, Ghannad L, Eng C, Patel J, Makovitch S, Chu SK, Babu AN, Walega DR, Marciniak C, Press J, Kennedy DJ, Plastaras C. Does Electrodiagnostic Confirmation of Radiculopathy Predict Pain Reduction after Transforaminal Epidural Steroid Injection? A Multicenter Study. J Nat Sci. 2015 Aug;1(8). pii: e140.
• 16. Bertrand H, Reeves KD, Bennett CJ, Bicknell S, Cheng AL. Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy. Arch Phys Med Rehabil. 2016 Jan;97(1):17-25.